Inventor · disambiguated record
James Loch
Also filed as: LOCH III JAMES T · LOCH III JAMES THOMSON · LOCH JAMES
10 granted patents·3 pending applications·52 citations·filing 1999–2021
88Inventor score
Top patents by PatentIndex Score
13 records- 0194US10472342B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2019·4 cites·25 claims
- 0290US10457655B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2017·Granted Oct 29, 2019·3 cites·46 claims
- 0390US10399951B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·5 cites·27 claims
- 0490US7196096B2Substituted amines of spirofuropyridines useful in therapyASTRAZENECA AB·Filed 2005·Granted Mar 27, 2007·16 cites·6 claims
- 0587US10450286B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 22, 2019·3 cites·27 claims
- 0686US10995078B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2020·Granted May 4, 2021·1 cites·2 claims
- 0779US10800750B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 13, 2020·0 cites·20 claims
- 0876US2021214323A1Novel compounds and compositions for inhibition of fasnFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0966US6995167B2Arylkylamine spirofuropyridines useful in therapyASTRAZENECA AB·Filed 1999·Granted Feb 7, 2006·20 cites·10 claims
- 1064US2016002188A1Novel compounds and compositions for inhibition of fasnFORMA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1158US10828315B2Targeted therapeuticsMADRIGAL PHARMACEUTICALS INC·Filed 2016·Granted Nov 10, 2020·0 cites·2 claims
- 1257US2021085700A1Targeted therapeuticsMADRIGAL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1355US10450251B2Process for the preparation of 3-substituted cannabinoid compoundsE THERAPEUTICS PLC·Filed 2016·Granted Oct 22, 2019·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →